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The lack of therapies for progressive multiple sclerosis highlights the need to 
understand the regenerative process of remyelination that can follow CNS 
demyelination. This involves an innate immune response consisting of microglia/ 
macrophages, which can be polarized to distinct functional phenotypes: pro-
inflammatory (M1) or anti-inflammatory/ immunoregulatory (M2).  Here we 
show that a switch from an M1- to M2-dominant response occurred within 
microglia and peripherally-derived macrophages as remyelination started. 
Oligodendrocyte differentiation was enhanced in vitro with M2 conditioned 
media, and impaired in vivo following intra-lesional M2 depletion. M2 densities 
were increased in lesions of aged mice in which remyelination was enhanced by 
parabiotic coupling to a younger animal, and in MS lesions that normally show 
remyelination. Blocking M2-derived activin-A inhibited oligodendrocyte 
differentiation during remyelination in cerebellar slice cultures. Our results 
therefore show that M2 polarization is essential for efficient remyelination and 
identify activin-A as a novel therapeutic target for CNS regeneration. 
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Remyelination, the formation of myelin sheaths around demyelinated axons by newly 
differentiated oligodendrocytes, can occur efficiently following central nervous 
system (CNS) demyelination. A major component of this regenerative process is a 
robust innate immune response consisting of peripherally-derived macrophages and 
their CNS-resident counterparts, microglia. Although these microglia/ macrophages 
are implicated in CNS autoimmune disease via secretion of toxic molecules 1 and 
antigen presentation to cytotoxic lymphocytes 2, they also exhibit regenerative 
properties through the phagocytosis of myelin debris 3, 4 and secretion of 
growth/neurotrophic factors 5. Regenerative properties of microglia/ macrophages 
following injury to muscle 6, 7 and skin 8 are associated with alternative or de-
activation to M2-polarized phenotypes (M2a and M2c, respectively), which secrete 
anti-inflammatory cytokines/ growth factors 9. In contrast, M1 'classically activated' 
phenotypes are associated with enhanced antigen presentation properties and secretion 
of pro-inflammatory cytokines and reactive oxygen/nitrogen species 9. In this study, 
we therefore explored the role of microglia/ macrophage polarization in 
remyelination, asking whether M2 phenotypes contribute to this regenerative response 
in the CNS and whether a study of M2-derived factors could lead to the identification 
of a novel target for remyelination therapies. 
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Results 
An M1 to M2 switch at the initiation of remyelination.  
To examine the timing of microglia/ macrophage polarization during remyelination, 
we induced focal demyelination by stereotaxic injection of lysolecithin into the mouse 
corpus callosum. Tissue was analyzed at 3, 10, and 21 days post lesion (dpl), times 
that correspond to key steps in the remyelination process: oligodendrocyte progenitor 
cell (OPC) recruitment into the lesion by proliferation and migration, initiation of 
remyelination by the differentiation of these OPCs into myelin-sheath forming 
oligodendrocytes, and completion of remyelination (Fig. 1a) 10-13. Studies of 
microglia/ macrophages with polarization state-specific markers revealed a switch 
from an M1- to M2-dominant phenotype at the initiation of remyelination. At 3 dpl, 
substantially more CD68+ microglia/ macrophages expressed the M1 marker 
inducible nitric oxide synthase (iNOS) than the M2 marker arginase-1 (Arg-1) (Fig. 
1b, c). However, by 10 dpl there were more Arg-1+ CD68+ M2 cells than iNOS+ 
CD68+ M1 cells (Fig. 1b, c). At 21 dpl, there was a reduction in Arg-1+ M2 cells 
compared to 10 dpl (Fig. 1b, c). Only a low percentage of CD68+ microglia/ 
macrophages remained unpolarized (iNOS– and Arg-1–) throughout remyelination 
(Fig. 1c). The polarization switch during remyelination was confirmed using 
additional markers for M1 (tumor necrosis factor (TNF)α and CD16/32) and M2 
phenotypes (mannose receptor (MR) and insulin-like growth factor (IGF)-1) 
(Supplementary Fig. 1 online). We also observed the same switch from an M1 to 
M2 response during remyelination in another model of demyelination induced by 
injection of ethidium bromide into the rat caudal cerebellar peduncles (CCP) 
(Supplementary Fig. 2 online) 14.  
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As the entry of peripherally-derived macrophages to function alongside CNS-resident 
microglia is an important part of the innate immune response in the CNS 5, 15, 16, we 
next determined whether this switch in polarization phenotype was a consequence of a 
change in the balance of (differentially-polarized) endogenous microglia vs. 
peripherally-derived macrophages, or of polarization switching in both populations. 
To exclude macrophages from lesions and therefore examine polarization only in 
microglia, we examined lesions created in C-C chemokine receptor 2 (CCR2)–/– mice 
whose peripheral monocytes (from which macrophages derive) cannot extravasate 4, 17 
and are thus excluded from entering remyelinating lesions 4 (Fig. 2a). The transition 
from M1 to M2 polarization still occurred as before within the microglia population in 
CCR2–/– mice, with the majority of CD68+ cells being iNOS+ at 3 dpl and Arg-1+ at 
10 dpl (Fig. 2b, c). However, the absence of peripherally-derived macrophages in 
CCR2–/– lesions did lead to a reduction in total numbers of iNOS+ M1 cells (to 37 ± 
10 and 33 ± 7 % of wildtype control at 3 and 10 dpl, respectively) and Arg-1+ M2 
cells (to 8 ± 8 and 40 ± 13 % of wildtype controls at 3 and 10 dpl, respectively). To 
examine polarization only in peripherally-derived macrophages within a lesion, green 
fluorescent protein (GFP)-expressing wildtype bone marrow-derived cells were 
injected into the circulation of lesioned CCR2–/– mice (Fig. 2d). Both GFP+ iNOS+ 
M1 macrophages and GFP+ Arg-1+ M2 macrophages were present at 3 and 10 dpl 
(Fig. 2e, f). The iNOS+ M1 population was composed of 39 ± 3 % (3 dpl) and 46 ± 
14 % GFP+ macrophages (10 dpl) whereas the Arg-1+ M2 population was composed 
of 63 ± 12 % (3 dpl) and 68 ± 23 % GFP+ macrophages (10 dpl), showing that 
macrophages contribute equally to both M1 and M2 populations before and during the 
switch in polarization. We conclude, therefore, that both peripherally-derived 
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macrophages and resident microglia contribute to the switch from M1 to M2 
phenotypes that we observed at the initiation of remyelination. 
 
M2 microglia promote oligodendrocyte differentiation.  
The switch from M1 to M2 polarization at 10 dpl led us to hypothesize that the two 
polarization states may have distinct roles in regulating the oligodendrocyte 
differentiation essential for the initiation of remyelination that occurs at this time. To 
test this, we first assessed the responses of OPCs to application of M1 and M2 
conditioned media in vitro. We used microglia rather than peripherally-derived 
macrophages since the former are always a component of the innate immune response 
regardless of changes to the blood-brain barrier, and we had confirmed above that 
microglia alone can undergo the switch in polarization in vivo. Microglia were 
polarized to M1 or one of two M2 subtypes (M2a (anti-inflammatory) and M2c 
(immuno-regulatory)) by exposure to interferon (IFN)-γ/ lipopolysaccharide (LPS), 
interleukin (IL)-13, and IL-10, respectively (Supplementary Fig. 3 online). We 
examined polarization by immunofluorescence, enzyme-linked immuno-absorbant 
assay (ELISA), and by gene expression profiling, confirming that the phenotypes 
matched those measured in vivo during remyelination 18 (Supplementary Fig. 3 and 
4 online).  
 
Conditioned media derived from both M1 and M2 microglia increased OPC 
proliferation (evidenced by increased total OPC numbers, cell cycle activity, and 5-
bromo-2-deoxyuridine (BrdU) incorporation (Supplementary Fig. 5a-d online)) and 
also increased chemotaxic migration (Supplementary Fig. 5e online). In contrast, 
only M2 conditioned media prevented OPC apoptosis in media deprived of serum and 
Nature Neuroscience 16, 1211–1218 (2013) doi:10.1038/nn.3469
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growth factors (Supplementary Fig. 6 online), conditions that reveal the 
physiological target-dependent survival mechanisms of newly-formed 
oligodendrocytes in vivo. Additionally, only M2 conditioned media increased 
oligodendrocyte differentiation, assessed by expression of myelin basic protein 
(MBP) (Fig. 3a, b) and myelin oligodendrocyte glycoprotein (MOG) (Fig. 3c).  
 
M2 depletion inhibits oligodendrocyte differentiation.  
Having revealed distinct effects of M1 and M2 conditioned media in cell culture, with 
only M2 conditioned media enhancing oligodendrocyte differentiation, we next 
determined the effect of selective depletion of each polarized macrophage population 
during remyelination in vivo. We depleted M1 cells by administration of gadolinium 
chloride (GdCl3) within a lesion, which upon phagocytosis induces apoptosis of 
inflammatory macrophages via competitive inhibition of Ca2+ mobilization and 
damage to plasma membranes 19-22. We confirmed the ability of GdCl3 (270 µM) to 
selectively deplete M1 cells in vitro (Supplementary Fig. 7a-c online) and within a 
lesion in vivo by injection at the time of lesioning (Fig. 4a-c and Supplementary Fig. 
7e, f online). GdCl3 injection did not significantly affect M2 cell numbers (Fig. 4c). 
M1 depletion reduced the density of proliferating cell nuclear antigen (PCNA)+ 
Nkx2.2+ proliferating OPCs at 3dpl compared to control (Fig. 4d), confirming a role 
for M1 polarization in regulating OPC proliferation. However, OPC migration (as 
measured by numbers of NG2+ or Nkx2.2+ OPCs) and remyelination were not 
impaired (Supplementary Fig.7g, h online).  
 
We depleted M2 cells using mannosylated clodronate liposomes (MCLs) that bind the 
mannose receptor (Fig. 5a) which is upregulated following M2 polarization 
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(Supplementary Fig. 3 online), and induce apoptosis within 2–3 days via clodronate-
mediated depletion of intracellular iron 23, 24.  We confirmed selective M2 depletion in 
vitro (Supplementary Fig. 8a-f online) and in vivo when MCLs were injected into a 
lesion at 8 dpl (Fig. 5b-d and Supplementary Fig. 8g, h online). M2 depletion 
caused an increase in the number and proportion of iNOS+ M1 cells (Fig. 5d and 
Supplementary Fig. 8g online), supporting previous findings of reciprocal regulation 
between M1 and M2 polarization and associated cytokines 25, 26. M2 depletion 
decreased expression of differentiation markers myelin associated glycoprotein 
(MAG) and MBP at 10 dpl (Fig. 5e, f), indicating a delay in oligodendrocyte 
differentiation. We measured the consequent delay in remyelination in tissue at 21 dpl 
following M2-depletion in two different ways. First, we observed decreased co-
localization of MBP and the late myelin marker MOG (Supplementary Fig. 8i 
online). Second, we demonstrated a decrease in the number of nodes of Ranvier 
normally indicative of compact myelin 27, 28 by showing reduced paranodal Caspr 
localization (flanking nodal Ankyrin-G) (Fig. 5g, h). No change was observed in 
lesion area (data not shown), numbers of Nkx2.2+ OPCs, presence of neurofilament 
(NF)+ axons, and glial fibrillary acidic protein (GFAP)+ astrocyte reactivity within 
the lesion (Supplementary Fig. 8j-l online).  
 
Increased M2 densities during efficient remyelination.  
These in vivo depletion experiments show that a switch to an M2 dominant phenotype 
in demyelinated lesions is required for efficient remyelination. We would predict, 
therefore, that experimental manipulations leading to increased numbers of M2 
macrophages would enhance remyelination.  To confirm this, we examined parabiosis 
experiments where the slow remyelination normally observed in old mice can be 
Nature Neuroscience 16, 1211–1218 (2013) doi:10.1038/nn.3469
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reversed by sharing a circulation with young mice 4, an effect mediated in part by 
recruitment of young circulating monocytes into the demyelinating lesions of the 
older mice. We analyzed previously-characterized tissue of lysolecithin-demyelinated 
ventral spinal cord of one of the two mice in various pairings 4 (Fig. 6a). Densities of 
M2 microglia/ macrophages (MR+ isolectin B4+ and Arg-1+ CD68+) were higher in 
the lesions of young animals paired to another young animal (Y/Y) than in old 
animals paired to another old animal (O/O) (Fig. 6b, c). Pairing of an old animal with 
a young animal (Y/O), a manipulation that restores remyelination efficiency in the 
older animal 4, led to increased densities of M2 microglia/ macrophages in the lesions 
in the older animal relative to those seen in the O/O pairings (Fig. 6b, c). In contrast, 
densities of CD16/32+ M1 microglia/ macrophages were substantially higher in O/O 
pairings than Y/Y pairings and not significantly reduced by Y/O pairing (Fig. 6d). 
Thus, increasing densities of M2 microglia/ macrophages is associated with enhanced 
remyelination efficiency. When we analyzed parabiosis experiments between a GFP-
expressing young mouse and a lesioned wild type old mouse 4 so as to assess the 
contribution of peripherally-derived young macrophages (GFP+) to the M1 and M2 
polarized populations within a remyelinating lesion (Fig. 6e), GFP+ iNOS+ CD68+ 
M1 macrophages and GFP+ Arg-1+ CD68+ M2 macrophages present within the 
lesion (Fig. 6f) only contributed to 3.6 ± 1.6 % of iNOS+ M1 cells and 12.4 ± 5 % of 
Arg-1+ M2 cells. The great majority of the increased numbers of M2 cells in the older 
animal of the Y/O pairings must therefore have derived from the microglia/ 
macrophages of the old animal, with the young macrophages that enter the lesion in 
the old CNS rejuvenating the lesion environment to promote M2 polarization of 
endogenous populations. 
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A second prediction of our conclusion that a switch to an M2-dominant phenotype in 
demyelinated lesions is required for efficient remyelination, and one critical for 
translational relevance, is that M2 macrophages will be abundant in areas of multiple 
sclerosis (MS) lesions associated with ongoing remyelination. To test this, we 
examined 5 patterns of MS lesion pathology (acute active, rim of chronic active, 
centre of chronic active, chronic inactive, remyelinated; Supplemental Table 1). All 
lesion types showed significantly higher densities of total CD68+ microglia/ 
macrophages and iNOS+ M1 cells compared to controls (Fig. 7d, f). While a few 
remyelinated lesions showed increased densities of MR+ M2 cells compared to 
controls, significantly elevated numbers of M2 cells were seen only in acute active 
lesions and within the rim of chronic active lesions (Fig. 7e, f, g), both areas of recent 
damage where ongoing remyelination would be expected.  
 
M2-derived activinA drives oligodendrocyte differentiation.  
Together, our data indicate that the switch to M2 polarization is an essential part of 
the regenerative response in the CNS by promoting oligodendrocyte differentiation. 
To identify an M2-derived regenerative factor, we took a candidate approach and 
investigated the transforming growth factor (TGF) β superfamily member activin-A in 
light of its neuroprotective properties 29, 30, and the upregulation of its receptor 
(Acvr2b) during remyelination 18. Activin-A is produced by inflammatory 
macrophages and is a marker of M2 polarization 31, 32.  In keeping with this, we found 
that more MR+ M2a and M2c polarized microglia expressed activin-A in vitro in 
comparison to iNOS+ M1 microglia (Fig. 8a). To confirm that M2 polarized cells 
also contribute activin-A to the environment of remyelinating lesions, we examined 
expression in lesions and found that activin-A immunoreactivity was more evident in 
Nature Neuroscience 16, 1211–1218 (2013) doi:10.1038/nn.3469
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association with MR+ M2 cells at 10 dpl compared to iNOS+ M1 cells at 3 dpl, and 
was reduced upon M2 depletion with MCLs (Fig. 8b). Examination of expression of 
receptors that directly bind activin-A, Acvr2A and Acvr2B, showed that NG2+ OPCs 
within remyelinating lesions expressed both subtypes (Fig. 8c). Importantly, OPCs 
also expressed Acvr1B, the receptor which is recruited by ligand-bound Acvr2 and 
which is required for subsequent functional downstream signalling 33. Together, these 
findings indicate the capacity of OPCs within remyelinating lesions to directly bind 
and respond to M2-derived activin-A. Assessment of activin-A binding capacity of 
other cell types within lesions indicates that Acvr2 is expressed by CC1+ 
oligodendrocytes (Acvr2B+) and CD68+ microglia/ macrophages (Acvr2A+, 
Acvr2B+), but not by GFAP+ astrocytes or NF+ axons (Supplementary Fig. 9 
online). 
 
To test the effect of activin-A on oligodendrocyte differentiation, we exposed cultured 
OPCs to activin-A and found it was sufficient to enhance oligodendrocyte 
differentiation (Fig. 8d). To confirm a role for activin-A in the differentiation-
promoting effect of M2 microglia, we supplemented cultures with M2 conditioned 
media and an activin-A blocking antibody and observed reduced oligodendrocyte 
differentiation (MBP+ cells) (Fig. 8e). Given that activin-A–/– mice are neonatally 
lethal, and activin receptor null mutants are either developmentally lethal or have 
gastrulation and fertility defects 34, 35, we investigated the role of activin-A in M2-
driven oligodendrocyte differentiation during remyelination in intact CNS using ex 
vivo organotypic cerebellar slice cultures (Fig. 8f). Following lysolecithin-induced 
demyelination, slices treated with M2 CM during the initiation of remyelination 
showed increased numbers of CC1+ MBP+ mature oligodendrocytes, which was 
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considerably reduced with anti-activin-A blocking IgG supplementation (Fig. 8g, h). 
This was due to blocking of activin-A in M2 conditioned media and not endogenous 
activin-A, as treatment of slices with anti-activin-A antibody alone did not reduce the 
number of oligodendrocytes relative to IgG control (Fig. 8h). Together, these data 
provide a molecular mechanism for M2-driven oligodendrocyte differentiation during 
remyelination via secretion of activin-A.  
Nature Neuroscience 16, 1211–1218 (2013) doi:10.1038/nn.3469
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Discussion 
Our results showed that a switch occurs from M1 to M2 polarization in both resident 
microglia and peripherally-derived macrophages in CNS lesions during 
remyelination. This switch occurs at 10 dpl corresponding to the time of 
differentiation of oligodendrocytes derived from OPCs that have been recruited into 
the lesion. Using cell culture, in vivo manipulation of macrophage populations, 
parabiosis experiments and correlative analysis of human MS lesions, we showed that 
M2 microglia/ macrophages drive oligodendrocyte differentiation during 
remyelination and that this is an essential part of an effective remyelination response. 
 
A switch from M1- to M2-associated gene expression has been reported during 
cutaneous wound healing 8 but has not been observed in studies of immune-mediated 
36 and toxin (cuprizone)-induced demyelination 37. This failure to observe a switch in 
different models of remyelination likely reflects the confounding effects of 
overlapping de- and remyelination phases in these models, and the consequent 
difficulty in establishing any correlation with the different stages of the regenerative 
process. Our choice of lesion model is the most appropriate to overcome this issue, as 
damage occurs at the time of toxin injection after which only the regenerative process 
is present.  
 
We have also shown, using organotypic cerebellar slice cultures, that this M2-driven 
regenerative response is mediated at least in part by secretion of the TGFβ 
superfamily member, activin-A. In accordance with our finding, signalling pathways 
downstream of activin receptor activation include Rac/Cdc42 GTPases, Akt, and 
mammalian target of rapamycin (mTOR), all of which have been previously 
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implicated in positively regulating oligodendrocyte differentiation and/or myelination 
38-41. Additionally, TGFβ isoforms have been shown to induce myelin protein 
expression 42, 43. Our novel finding implicating activin-A in the regulation of 
oligodendrocyte differentiation together with evidence of activin-A’s neuroprotective 
properties 29,  30,  the expression of its receptors on OPCs in remyelinating lesions, and 
the upregulation of its receptor during remyelination 18, highlights this factor as a 
promising novel therapeutic target for CNS myelin regeneration.  
 
Whereas previous studies investigating microglia/ macrophage polarization in the 
context of neuronal injury have highlighted the neuroprotective properties of M2 cells 
44, 45, in this study we have identified the regenerative capacity of M2 cells in the 
CNS.  Our results showing that M2 cells are required for oligodendrocyte 
differentiation are of particular interest given that a block in oligodendrocyte 
differentiation is a feature of chronic MS lesions 46. Our results also have implications 
for the use of immuno-modulatory MS therapies; the CNS-permeable therapy 
FTY720 decreases peripheral M1 and M2 polarization in rodents 47, whereas 
glatiramer acetate induces a peripheral M2 phenotype 48, although any effect on 
central M2 polarization remains undetermined. We suggest that cell- or drug-based 
therapies founded on manipulating M2 polarization and/or activin-A expression in the 
CNS represent complementary regenerative strategies that may support remyelination 
and clinical recovery in MS. 
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Figure Legends 
Figure 1 A switch from an M1 to an M2-dominant microglia/macrophage response 
occurs at the initiation of remyelination.  
(a) Oligodendroglial lineage cell responses in the corpus callosum at 3, 10, and 21 
days post lesion (dpl) induction by stereotactic injection of lysolecithin (LPC). (b) 
Lesions immunostained against iNOS (green), Arg-1 (red), and CD68 (white) at 3, 10 
and 21 dpl. Inset: isotype controls. Scale bar, 25 µm. (c) Percentage of iNOS+ M1 
cells, Arg-1+ M2 cells, and iNOS–Arg-1– (unpolarized) cells per field in lesion ± 
s.e.m.. One way ANOVA and Newman-Keuls post-hoc test, ***p<0.001 (n=5 mice, 
df=44).  
 
Figure 2 Microglia and peripherally-derived macrophages contribute to both M1 and 
M2 polarized populations during remyelination. 
(a) Ccr2–/– mice were lesioned in the corpus callosum to examine polarization in 
microglia only. (b) Ccr2–/–  lesions at 3 and 10 dpl immunostained against iNOS 
(green), Arg-1 (red) and CD68 (white). Scale bar, 25 µm. (c) Percentage of iNOS+, 
Arg-1+, or unpolarized (iNOS–, Arg-1–) cells in Ccr2–/– lesions ± s.e.m.. One way 
ANOVA and Newman-Keuls post-hoc test, ***p<0.001 (n=2-3 mice, df=14). (d) 
Ccr2–/–mice were lesioned in the corpus callosum and injected with GFP-expressing 
wildtype bone marrow derived cells to examine polarization in peripherally-derived 
macrophages only. (e) GFP+ macrophages (stars) and GFP– microglia (hash symbols) 
were iNOS+ (white) or Arg-1+ (red). Scale bar, 5 µm. (f) Numbers of GFP+ 
(macrophages) (black bars) and GFP– (microglia)(white bars) iNOS+ M1 and Arg-1+ 
M2 cells per field ± s.e.m. (n=3 mice). 
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Figure 3 M2 conditioned media promotes oligodendrocyte differentiation. 
(a) OPCs treated with unconditioned (control) or M1, M2a, or M2c conditioned media 
immunostained against NG2 (green) and MBP (red). Scale bar, 50 µm. (b) Percentage 
of MBP+ cells ± s.e.m. following treatment with microglia conditioned media, or 
polarizing factors alone as a control., Kruskal-Wallis test and Dunn’s multiple 
comparison post-test, ***p<0.001 (n=3 separate experiments). (c) Number of MOG+ 
cells per field ± s.e.m. following treatment with microglia conditioned media. 
Kruskal-Wallis test and Dunn’s multiple comparison post-test, **p<0.01 (n=3 
separate experiments). 
 
Figure 4 Selective depletion of M1 microglia/ macrophages in a demyelinated lesion 
in the CNS impairs OPC proliferation. 
(a) Gadolinium chloride (GdCl3) was injected into corpus callosum lesions at the 
onset of demyelination (0 dpl) prior to the peak in M1 polarization at 3 dpl. (b) 
Representative images of control or GdCl3-injected lesions at 3 dpl with 
immunostaining against iNOS (green), Arg-1 (red), and CD68 (white). Scale bar, 25 
µm. (c) Numbers of iNOS+ M1, Arg-1+ M2, or unpolarized (iNOS–, Arg-1–) cells 
per field ± s.e.m. in control and GdCl3-injected lesions at 3 dpl. One way ANOVA 
and Newman-Keuls post-test, **p<0.01 (n=5 mice, df=29). (d) Density of PCNA+ 
Nkx2.2+ proliferating OPCs per mm2 in control and GdCl3-injected lesions ± s.e.m. 
at 3 dpl. P=0.0496, 2-tailed Student’s t-test (n=5 mice, df=8).  
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Figure 5 Selective depletion of M2 microglia/ macrophages in a demyelinated lesion 
in the CNS impairs oligodendrocyte differentiation. 
(a) Mannosylated clodronate liposomes were used to induce apoptosis selectively in 
M2 polarized microglia/ macrophages due to upregulation of mannose receptor, and 
induce clodronate-mediated apoptosis following phagocytosis. (b) Corpus callosum 
lesions were injected with MCLs at 8 dpl prior to the peak in M2 polarization at 10 
dpl. (c) Representative images at 10 dpl of control and MCL-injected lesions 
immunostained for iNOS (green), Arg-1 (red), and CD68 (white). Scale bar, 25 µm.  
(d) Number of iNOS+ M1, Arg-1+ M2, or unpolarized (iNOS–, Arg-1–) cells per 
field ± s.e.m. in control and MCL-injected lesions at 10 dpl. One way ANOVA and 
Newman-Keuls post-test, **p<0.01, ***p<0.001 (n=5 mice, df=29). (e) Mean lesion 
pixel counts ± s.e.m. for MAG and MBP at 10 dpl. 2-tailed Student’s t-test versus 
control, P=0.0361 and 0.0106, respectively (n=4-5 mice, df=7). (f) Representative 
images of lesions (dotted outline) at 10 dpl in control and MCL-injected lesions 
immunostained against MBP (red) and MAG (green). Scale bar, 100 µm. (g) 
Quantification of nodes of Ranvier (paranodal Caspr expression flanking nodal 
Ankyrin-G expression) ± s.e.m. in control and MCL-treated lesions at 21 dpl. 2-tailed 
Student’s t-test versus control, P=0.0068 (n=6 mice, df=10). Box plots indicate 
median (centre line), 25th -75th percentile (box limits) and minimum and maximum 
(whiskers). (h) Representative images of control and MCL-treated lesions at 21 dpl 
immunostained against Caspr (green) and Ankyrin-G (red). Scale bar, 25 µm. 
 
Figure 6 Restored remyelination efficiency in aged mice via heterochronic parabiosis 
is associated with increased densities of M2 polarized cells. 
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 (a) Lesion induction in the ventral spinal cord by lysolecithin injection. Parabiotic 
pairings between young (Y-Y) (white) or old (O-O) (dark gray) animals were 
compared to lesions in old animals following heterochronic pairing (Y-O) (light gray), 
with previous studies showing restored remyelination efficiency in old partners of Y-
O pairings. (b) Lesions immunostained at 7 dpl against Arg-1 (red) and CD68 (white). 
Scale bar, 25 µm. (c) MR+ IB4+ M2 cells/ 0.1 mm2 ± s.e.m. at 7 dpl. 2-tailed 
Student’s t-test: Y/Y vs. O/O, P=0.048; Y/O vs. O/O, P=0.005 (n=4 (O/O), 6(Y/O), 4 
(Y/Y), df=13). (d) CD16/32+ IB4+ cells/0.1 mm2 ± s.e.m. at 7 dpl. 2-tailed Student’s 
t-test: Y/Y vs. O/O, P=0.0027; Y/Y vs. Y/O, P=0.014 (n=4 (O/O), 6(Y/O), 4 (Y/Y), 
df=13). (e) Parabiosis between a GFP–expressing young mouse and wildtype (WT) 
old mouse with a spinal cord lesion. (f) GFP expressing iNOS+ CD68+ M1 
macrophages and Arg-1+ CD68+ M2 macrophages. Scale bar, 5 µm.  
 
Figure 7 M2 microglia/ macrophage densities are increased in acute active and the 
rim of chronic active multiple sclerosis lesions. 
(a) Total CD68+ microglia/ macrophages/ mm2 were significantly increased in acute 
active (P=0.001), chronic active rim (P=0.0156) and centre (P=0.0156), chronic 
inactive (P=0.001) and remyelinated lesions (P=0.002). (b) iNOS+ M1 microglia/ 
macrophages/ mm2 were increased in acute active (P=0.001), chronic active rim 
(P=0.0156) and centre (P=0.0313), chronic inactive (P=0.0005), and remyelinated 
lesions (P<0.0001). (c) MR+ M2 microglia/ macrophages / mm2 were increased in 
acute active lesions (P=0.0068) and the rim of chronic active lesions (P=0.0156). 
Mann-Whitney test. n for each lesion type indicated in Supplementary Table 1 
online. (d) Representative image of MS lesion with iNOS immunolabeling. Scale bar, 
100 µm. (e) Representative image of MS lesion with MR immunolabeling. Scale bar, 
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100 µm. (f) Co-localization of MR (top) and iNOS (bottom) with microglia/ 
macrophage marker CD68 (arrowheads). Scale bar, 25 µm. (g) MR+ CD68+ M2 cells 
(arrows) were sometimes associated with blood vessels. Scale bar, 25 µm. 
 
Figure 8 Activin-A is an M2-derived factor that drives oligodendrocyte 
differentiation during remyelination. 
(a) Percentage of activin-A immunopositive cells per field in M1, M2a, and M2c 
microglia ± s.e.m. (b) Control corpus callosum lesions at 3 and 10 dpl (top and middle 
panels) and MCL-injected lesion at 10 dpl (bottom panel) immunostained for activin-
A (red) and iNOS or MR (green). Scale bar, 25 µm. (c) Representative images of 
NG2+ OPCs (green) in remyelinating lesions expressing activin receptors Acvr2A, 
Acvr2B, and Acvr1B (red; arrows). Scale bar, 10 µm. (d) Percentage of MBP+ cells ± 
s.e.m. in OPC cultures treated with activin-A. One way ANOVA and Newman-Keuls 
post-hoc test, *p<0.05 (n=4 separate experiments, df=15). (e) Percentage of MBP+ 
cells ± s.e.m. in OPC cultures treated with combinations of M2a conditioned media, 
goat isotype control IgG, or goat anti-activin-A antibody. One way ANOVA and 
Newman-Keuls post-hoc test, **p<0.01 (n=4 separate experiments, df=11), 
ns=p>0.05. (f) 300 µm sagittal sections of cerebellum and attached hindbrain were 
taken from newborn mouse brain to obtain organotypic cultures, demyelinated with 
lysolecithin (LPC) and treated with M2 conditioned media and either anti-activin-A 
IgG or control goat IgG. (g) Representative images of slices treated with M2 
conditioned media and goat IgG (left) or anti-activin-A antibody (right) 
immunostained for CC1 (white) and MBP (red). Scale bar, 25 µm. (h) Percentage of 
CC1+ oligodendrocytes normalized to values obtained from slices treated with IgG 
alone. 2-tailed one-sample or Student’s t-test (respectively), M2 conditioned media + 
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IgG vs. IgG, P=0.0213; M2 conditioned media + IgG vs. M2 conditioned media + 
anti-activin-A IgG, P=0.0071 (n=8 slices, df=14). Box plots indicate median (centre 
line), 25th-75th percentile (box limits), minimum and maximum (whiskers).
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Supplemental Material 
 
Supplementary Figure 1 Additional characterization of polarization in corpus 
callosum lesions.  
(a)  Representative images of sham PBS-injected lesions at 3 and 10 dpl 
immunostained for iNOS (green), Arg-1 (red), and CD68 (white). (b) Co-localization 
of iNOS and Arg-1 in microglia/ macrophage cell bodies (CD68; arrows) and 
processes (F4/80). 3 and 10 dpl lesions immunostained for additional M1 markers (c; 
TNFα, CD16/32) and M2 markers (d; MR, IGF-1). All scale bars, 25 µm. 
 
Supplementary Figure 2 Switch from M1- to M2-dominant response in 
remyelinating lesions of the rat caudal cerebellar peduncle.  
(a) Oligodendroglial lineage cell responses following induction of demyelination of 
the caudal cerebellar peduncle by stereotaxic injection of ethidium bromide (EtBr). 
Scale bar, 100 µm. (b) Injection of demyelinating toxin induces accumulation of 
microglia (CD68+; red) at 5 dpl. Recovery of myelin protein expression is observed 
with re-expression of MAG at 10 dpl (c, centre) and MBP at 21 dpl (c, right). (d) 
Microglia/ macrophages (CD68+; purple) are present at 5 dpl, increase in abundance 
at 10 dpl, and decrease in number by 21 dpl. (e) Representative images of lesions 
immunostained for iNOS (green) and Arg-1 (red). Percentage (f) and mean number 
(g) of iNOS+ M1, Arg-1+ M2, and unpolarized (iNOS– Arg-1–) cells per field ± 
s.e.m. at 5, 10, and 21 dpl. One-way ANOVA and Newman-Keuls post test, *p<0.05, 
**p<0.01. (n=3, df=26, 17, respectively). (h) 5 and 10 dpl sections immunostained for 
additional M1 (TNFα, CD16/32) and M2 (IGF-1, MR) markers. All other scale bars, 
25 µm. 
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Supplementary Figure 3 Polarization of cultured microglia to M1 and M2 
phenotypes.  
(a) Representative images of microglia immunostained against M1 markers iNOS, 
CD86, CD16/32 (top) and M2 markers MR, Arg-1, and IL1Ra (bottom). Scale bar, 25 
µm. (b) Mean percentage of iNOS+ or MR+ cells of total CD68+ cells ± s.e.m.. 
Kruskal-Wallis test and Dunn’s multiple comparison post-hoc test, *p<0.05, 
**p<0.01, ***p<0.001. (n=4) (c) Cropped Western blots showing expression of iNOS 
with IFNγ/LPS treatment and increase in MR expression with IL-13 or IL-10 
treatment, with loading control GAPDH. ELISAs used to assay conditioned media for 
levels of TNFα (d; P=0.0004, n=5, df=8), IGF-1 (e; P=0.0330, n=3, df=4), and IL-10 
(f; P=0.0051, n=5, df=8), presented as mean fold over M0 control ± s.e.m. 
demonstrating polarization to M1, M2a, and M2c, respectively. A small yet 
significant increase in IL-10 secretion was observed with IFNγ/ LPS treatment (P 
=0.0081). Polarizing factors alone were included in the assay as a control and did not 
show detectable levels relative to those measured in conditioned media (d-f). 2-tailed 
Student’s t-test. 
 
Supplementary Figure 4 M1 and M2 associated gene expression in cultured 
microglia. 
(a) M1- and M2-associated genes were identified from a previously performed 
microarray18 as being significantly upregulated during remyelination of the rat caudal 
cerebellar peduncles (CCP). These genes were selected for a custom qPCR array to 
assess gene expression profiles of polarized microglia in vitro. (b) Confirmation of 
expression of additional polarization markers CD86, CCL2, CXCL11, and TGFβ2 in 
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iNOS+ or Arg-1+ cells in the rat CCP. Scale bar, 5 µm. Microglia treated with 
IFNγ/LPS (M1), IL13 (M2a), and IL10 (M2c) were analyzed for gene expression 
levels of (c) Cd86, (d) Cxcl11, (e) Ccl2, (f) Fcgr2a (Cd32), (g) Mrc1(mannose 
receptor), (h) Tgfb2, and (i) Arg1, values are represented as 2-∆Cp ± s.e.m. 
 
Supplementary Figure 5 M1 and M2 microglia conditioned media increase OPC 
proliferation and migration.  
OPCs were treated with microglia conditioned media for 3d. Polarizing factors 
present in the conditioned media (IFNγ/LPS, IL-13, and IL-10) were directly applied 
to OPCs as a control. (a) Representative images of OPCs immunostained against NG2 
(green) and the proliferative marker Ki67 (red). Double-positive cells are highlighted 
by arrows. Scale bar, 25 µm. (b) Number of NG2+ cells per field was increased with 
M0 (P=0.005), M1 (P=0.00188), M2a (P=0.00382), M2c (P=0.0119) conditioned 
media (CM), and IL-10 (P=0.0029) compared to control (n=5, df=8). (c) 
Ki67+/NG2+ cells were increased with M0 (P=0.0084), M1 (P=0.0362), M2a 
(P=0.0194), M2c (P=0.0192) conditioned media (n=4, df=6) (d) BrdU+ cells were 
increased with M1 (P=0.042), M2a (P=0.0083) and M2c conditioned media 
(P=0.0423) (n=4, df=6). Values from conditioned media-treated conditions (black 
bars) and polarizing factors alone (grey bars) were normalized to control 
(unconditioned media, white bars) in (c) and (d), and are represented as mean ± 
s.e.m., 2-tailed Student’s t-test. (e) Number of OPCs ± s.e.m. migrated towards 
microglia conditioned media (black bars), or polarizing factors alone (grey bars), 
normalized to values in control (unconditioned media, white bar) showing 
chemotactic properties of both M1 and M2 conditioned media. Kruskal-Wallis test 
and Dunn’s multiple comparison post-test, **p<0.01, ***p<0.001. (n=3). 
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Supplementary Figure 6 M2 polarized microglia conditioned media promotes the 
survival of OPCs in a death-inducing environment.  
OPCs were treated with microglia conditioned media for 3d in media devoid of serum 
and growth factors. Polarizing factors present in the conditioned media (IFNγ/LPS, 
IL-13, and IL-10) were directly applied to OPCs as a control. (a) Representative 
images of OPCs under basal growth supplemented conditions, grown in deprivation 
media alone, or supplemented with microglia conditioned media. OPCs were 
immunostained against NG2 (red) and apoptotic OPCs were visualized by TUNEL 
assay (green). Scale bar, 50 µm. (b) Mean percentage of TUNEL+ NG2+ OPCs 
normalized to control supplemented with growth factors and media ± s.e.m.. DNase 
and ethanol treatment were positive controls for TUNEL positivity. Application of 
microglia conditioned media to OPCs under normal growth conditions did not induce 
apoptosis (data not shown). Kruskal-Wallis test and Dunn’s multiple comparison 
post-test, *p<0.05, **p<0.01. (n=6).  
 
Supplementary Figure 7 Selective depletion of M1 polarized microglia/ 
macrophages using gadolinium chloride. 
(a) Representative images of M1 (iNOS+; left) and M2a (MR+; right) microglia 
treated with 270 µm GdCl3 and apoptosis assessed by TUNEL assay (green nuclei). 
Apoptotic cells are indicated by arrowheads, and were iNOS+ and MR–. Scale bar, 25 
µm. (b) Percentage of TUNEL+ M1 microglia treated with vehicle (ctrl), or GdCl3 
(0.27-270 µm). Mann-Whitney test, P=0.0286. (n=4). (c) Mean percentage of 
TUNEL+ cells ± s.e.m. in M0, M1, M2a, and M2c polarized microglia treated with 
vehicle or 270 µm GdCl3. One-way ANOVA and Newman-Keuls post-hoc test, 
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**p<0.01 (n=6, df=54). (d) GFAP immunostaining in representative control and 
GdCl3-injected lesions shows no difference in astrocyte reactivity. Scale bar, 25 µm. 
(e) Percentage of iNOS+ or Arg-1+ cells in control or GdCl3-injected lesions, 
P=0.0135 (iNOS), 0.0319 (Arg-1), 2-tailed Student’s t-test (n=5, df=8). (f) GdCl3-
injected lesions immunostained for M1 markers (iNOS, TNFα, CD16/32) and M2 
markers (MR, IGF-1) at 3 dpl. Scale bar, 25 µm. (g) NG2+ (n=4, df=6) and Nkx2.2+ 
(n=5, df=8) cells per field in control and GdCl3-treated lesions at 3 dpl. 2-tailed 
Student’s t-test, p>0.05. (h) Mean area of MBP and MOG co-localization, fold over 
control ± s.e.m. in lesions at 21 dpl. P=0.081, 2-tailed Student’s t-test (n=6, df=10). 
 
Supplementary Figure 8 Selective depletion of M2 polarized microglia/ 
macrophages using mannosylated clodronate liposomes. 
(a) Representative images of iNOS+ M1 and MR+ M2a microglia treated with MCLs 
(1:5) and assessed for apoptosis by TUNEL assay. In M1 polarizing conditions, 
iNOS+ cells were TUNEL– (arrows); TUNEL+ cells were iNOS– (arrowheads). In 
M2a polarizing conditions, TUNEL+ cells were MR+ (arrowheads), whereas MR– 
cells were TUNEL– (arrows). (b) Mean percentage of TUNEL+ cells ± s.e.m. in M0, 
M1, M2a, and M2c polarized microglia treated MCLs (1:5 dilution), normalized to 
values from M0 conditions. P=0.027 (M1 vs. M2a), P=0.013 (M1 vs. M2c), 2-tailed 
Student’s t-test (n=6, df=10). Mean percentage of TUNEL+ cells ± s.e.m. in M2a (c, 
P=0.015, df=7) and M2c (d, P=0.0251, 0.0016, 0.03 for 1:50, 1:10, 1:5, respectively, 
df=6) microglia treated with MCLs (1:200-1:5; black bars) compared to control 
(white bars) (n=4). Mean numbers of microglia per field ± s.e.m. for M2a (e, P=0.02, 
0.03, 0.009, 0.007 for 1:100, 1:50, 1:10, 1:5, respectively, df=6) and M2c (f; 
P=0.0003, <0.0001, 0.0005, 0.0005 for 1:100, 1:50, 1:10, 1:5, respectively, df=6) 
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polarized cells treated with MCLs (1:200-1:5; black bars) compared to control (white 
bars), 2-tailed Student’s t-test (n=4). (g) Percentage of iNOS+ M1, Arg-1+ M2, or 
unpolarized (iNOS–, Arg-1–) cells per field ± s.e.m. in control and MCL-injected 
lesions at 10 dpl. P<0.0001, 2-tailed Student’s t-test (n=5, df=8). (h) MCL-injected 
lesions immunostained for additional M1 (iNOS, TNFα, CD16/32) and M2 markers 
(MR, IGF-1). Scale bar, 25 µm. (i) Mean area of MBP and MOG colocalization fold 
over control ± s.e.m. in lesions at 21 dpl. 2-tailed Student’s t-test, P=0.0002 (n=6, 
df=10). (j) Axons (NF+) were detectable running through the lesion (MBP–) at 10 dpl 
following MCL injection. (k) MCL injection did not influence astrocytes (GFAP+) 
within the lesion. Scale bar, 25 µm. (l) Total numbers of Nkx2.2+ OPCs ± s.e.m. in 
control and MCL injected lesions. 2-tailed Student’s t-test, p>0.05 (n=4, df=6).  
 
Supplementary Figure 9 Expression of activin-A receptors on cells in remyelinating 
lesions.  
Representative images of oligodendrocytes (CC1+), microglia/ macrophages 
(CD68+), astrocytes (GFAP+), and neurons (axons; NF+) with expression, or lack 
thereof, of activin-A receptors Acvr2A and Acvr2B. Scale bar, 10 µm.
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Supplemental Table 1. Human brain tissue samples 
 
 
C
lassific-
ation 
Sex 
A
ge 
D
isease 
duration 
(yrs)
 
B
lock 
Lesions Analyzed 
A
ctive 
C
hronic 
A
ctive 
C
hronic 
Inactive 
R
em
yel-
inated 
 
 
 
 
 
Multiple 
Sclerosis 
Patients 
SPMS M 46 8 P2E3 0 0 2 2 
P3E3 1 0 1 1 
SPMS F 49 14 A3D3 3 0 0 0 
SPMS M 40 9 P3B4 1 0 1 3 
SPMS F 60 21 P3C3 1 1 1 0 
SPMS F 34 21 A2D7 1 0 0 0 
A2E2 1 0 1 1 
PPMS M 37 27 P4D1 0 0 1 3 
SPMS F 57 27 P3D1 0 0 0 2 
SPMS F 46 25 A2B3 0 1 1 0 
P2C4 0 2 0 1 
SPMS F 42 19 A2C2 2 0 0 1 
SPMS F 57 19 P3C4 0 2 3 0 
                                                                                   TOTAL 10 6 11 14 
 
 
 
 
Non-
Neurological 
Controls 
Carcinoma of 
the lung 
metastasized 
M 77 - P3B4 - - - - 
Cardiac failure M 64 - P2D2 - - - - 
Carcinoma of 
the tongue 
M 35 - P3B3 - - - - 
Ovarian 
cancer 
F 60 - P3D2 - - - - 
Myelodysplast
-ic syndrome, 
Rheumatoid 
Arthritis 
M 82 - A2C7 - - - - 
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ONLINE METHODS 
In vivo focal CNS white matter demyelinating lesions and parabiosis. 
Demyelinating lesions were induced in the corpus callosum of 10-17 week-old male 
C57BL/6 mice or the caudal cerebellar peduncles of 12 week-old female Sprague 
Dawley rats by stereotaxic injection of 2 µl of 1% lysolecithin (v/v) or 4 µl of 0.01% 
ethidium bromide (v/v), respectively, using a Hamilton syringe. Sham lesions were 
induced by phosphate buffered saline (PBS) injection. Lesions were also induced in 
the corpus callosum of 10 week-old male CCR2 null mice (B6.129S4-Ccr2tm1lfc/J; The 
Jackson Laboratory). A subset of these underwent tail vein injections of 5x106 bone 
marrow cells derived from GFP mice of the same age/ sex (C57BL/6-Tg(CAG-
EGFP)131Osb/LeySopJ;The Jackson Laboratory) 1 day prior to lesioning (for 3 day 
time points) or 8 days post lesion (for 10 day time points). Animals were 
intracardially perfused with 4% paraformaldehyde (PFA), and brains were post-fixed 
overnight and cryoprotected in sucrose prior to OCT embedding (Tissue-Tech) and 
storage at -80°C. All experiments were performed under the UK Home Office project 
licences issued under the Animals (Scientific Procedures) Act. C57BL/6 isogenic or 
congenic female mice were joined by parabiosis as previously described 4. Isochronic 
parabiosis involved young-young pairs (5-7 weeks old) and old-old pairs (10-12 
months old), whereas heterochronic parabiosis involved young-old pairs (young 
partner was wildtype or GFP-expressing (C57BL/6-UBC-GFP; Jackson 
Laboratories)). Demyelinated lesions were induced in the ventral funiculus of the 
thoracic column of the spinal cord by injection of 1% lysolecithin 4 and animals 
perfused as above. These experiments were carried out at the Joslin Diabetes Centre 
animal facility (Boston, MA) and the BRI animal facility in the Department of Stem 
Cell and Regenerative Biology (Harvard University, Cambridge, MA) in compliance 
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with guidelines from the Institutional Animal Care and Use Committee (IACUC) of 
Joslin Diabetes Centre and Harvard University. 
 
Selective depletion of M1 or M2 microglia in focal demyelinated lesions. GdCl3 
(Sigma; 0.27-1000 µM) was applied to microglia in vitro during polarization to assess 
its specificity in inducing apoptosis in M1 phenotypes by terminal deoxynucleotidyl 
transferase dUTP nick end labelling (TUNEL) assay. PBS or GdCl3 (270 µM) was 
stereotaxically co-injected into the corpus callosum of mice with lysolecithin and 
depletion of M1 microglia/ macrophages was assessed at 3dpl. Mannosylated 
clodronate (dichloromethylene diphosphonate; Cl2MDP)-encapsulated liposomes 
(Encapsula Nano Sciences) were applied to polarized microglia in vitro diluted in 
culture media (1:5-1:200) to assess specificity in promoting M2 apoptosis by TUNEL 
assay. PBS or undiluted clodronate liposomes were stereotaxically injected into the 
lesion site at 8 dpl and depletion of M2 microglia/ macrophages was assessed at 10 
dpl. 
 
Immunohistochemistry. Slides were air-dried, permeabilized, and blocked for 1h 
and primary antibody applied overnight at 4°C in a humid chamber. Fluorescently-
conjugated secondary antibodies were applied for 2 h at room temperature in a humid 
chamber (1:500, Molecular Probes and Jackson ImmunoResearch). Biotin-conjugated 
isolectin B4 (1:100, Sigma Aldrich L-2140) was labelled with avidin-Alexa 488 
(1:500, Molecular Probes). Following counterstaining with Hoechst, slides were 
coverslipped with Fluoromount-G (Southern Biotech). Antibody isotype controls 
(Sigma) added to sections at the same final concentration as the respective primary 
antibodies showed little or no non-specific staining. Antibodies used to detect M1 
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microglia/ macrophage markers are as follows: mouse anti-iNOS (BD Biosciences, 
610329, 1:100), rat anti-CD16/32 (BD Pharmingen, 553141/2, 1:500), goat anti-TNFα 
(R&D Systems, AB-410-NA, 1:500), rabbit anti-CD86 (Abcam, ab53004, 1:100), 
rabbit anti-CCL2 (Biorbyt, orb36895, 1:100), and rabbit anti-CXCL11 (Biorbyt, 
orb33040, 1:100). Antibodies used to detect M2 markers are as follows: goat anti-
Arginase-1 (Santa Cruz Biotechnology, sc-18355, 1:50), rabbit anti-mannose receptor 
(Abcam, ab64693, 1:600), goat anti-IGF-1 (R&D Systems, AF791, 1:100), rabbit anti 
IL1Ra (Santa Cruz Biotechnology, sc-25444, 1:100), and goat anti-pan TGFβ (R&D 
Systems, AB-100-NA,1:500). Antibodies used against pan microglia/ macrophage 
markers include rat anti-CD68 (Abcam, ab53444, 1:100) and rat anti-F4/80 (Abcam, 
ab6640, 1:100). Oligodendrocyte and myelin antigens were detected by rabbit or 
mouse anti-NG2 (Millipore, MAB5384/ 5320, 1:200, 1:100, respectively), mouse 
anti-Nkx2.2 (Developmental Hybridoma Bank, clone 74.5A5-c, University of Iowa, 
1:100), mouse anti-CC1 (Abcam, ab16794, 1:100), rat anti-MBP (AbD Serotec, 
MCA409S, 1:250), rabbit anti-damaged MBP (Millipore, AB5864, 1:100), and mouse 
anti-MOG and anti-MAG (Millipore, MAB5680/ 1567, 1:100). Antibodies to detect 
nodes of Ranvier include rabbit anti-Caspr (Abcam, ab34151, 1:500) and mouse anti-
Ankyrin-G (UC Davis/ NIH NeuroMab Facility, clone N106/36, 1:200). Antibodies 
against activin-A or its receptors include goat anti-activin-A (AF338), anti-Acvr1B 
(AF1477), anti-Acvr2A (AF340), and anti-Acvr2B (AF339) (all from R&D Systems, 
1:40). Other antibodies include chicken anti-NFH (Encor Biotechnology, Inc., CPCA-
NF-H, 1:10,000), rabbit anti-GFAP (DAKO, Z0334, 1:500), rabbit anti-Ki67 (Abcam, 
AB9620, 1:100), rabbit anti-PCNA (Abcam, ab2426-1, 1:100), and chicken anti-GFP 
(Abcam, ab13970, 1:100). 
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Microglia and OPC Culture. Cortical mixed glial cultures were generated from 
Sprague Dawley rat postnatal day 0-2 pups. Microglia were isolated by collecting the 
floating fraction of 10 day-old mixed glial cultures following 1 hr on a rotary shaker 
at 37°C at 250 rpm, and plated in Dulbecco’s modified essential media (DMEM) 
containing 4.5 g/L glucose, L-glutamine, pyruvate, 10% fetal calf serum, and 1% 
penicillin/streptomycin (‘DMEM 10%’; GIBCO) on poly-D-lysine (PDL)-coated 16-
well glass chamberslides (Lab-TEK) at 5x104 cells/well, or at 1x106 cells/ well on 
PDL-coated glass coverslips in a 24 well plate. For survival experiments, microglia 
were grown in serum-free media to avoid confounding pro-survival effects of serum 
in the conditioned media; successful polarization under these growth conditions was 
confirmed (data not shown). OPCs were isolated by collecting the floating fraction of 
10 day-old mixed glial cultures following depletion of microglia as above, 16 hr on a 
rotary shaker at 37°C at 250 rpm, and depletion of astrocytes by differential adhesion. 
OPCs were plated in  DMEM containing 4.5 g/L glucose, L-glutamine, pyruvate, 
SATO (16 µg/ml putrescine, 400 ng/ml L-thyroxine, 400 ng/ml tri-iodothyroxine, 60 
ng/ml progesterone, 5 ng/ml sodium selenite, 100 µg/ml bovine serum albumin 
fraction V, 10 µg/ml insulin, 5.5 µg/ml halo-transferrin (all from Sigma-Aldrich)), 
0.5% fetal calf serum (GIBCO), 1% penicillin/streptomycin, 10 ng/ml platelet-derived 
growth factor, and 10 ng/ml fibroblast growth factor-2 at 2x104 cells per well in PDL-
coated plastic chamberslides (Lab-TEK). OPCs were treated for 3 days with microglia 
media as a control or conditioned media added in a 1:1 ratio to OPC culture media. 5-
bromo-2'-deoxyuridine (BrdU) was added to OPC cultures for 24 h prior to fixation. 
Activin-A (1-100 ng/ml; R&D Systems) or vehicle (0.1% BSA in PBS) was added to 
OPCs for 3 days. Goat anti-activin-A (βA subunit) blocking antibody (200 ng/ml; 
R&D Systems) or goat IgG control (200 ng/ml; Santa Cruz Biotechnology, Inc.) 
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diluted in OPC culture media was added to cultures with M2a conditioned media in a 
1:1 ratio for 3 days. All assays represent a minimum of 3 independent experiments 
treated with conditioned media from at least 3 microglial preparations. 2-4 20X or 
40X objective images were taken per condition per experiment for quantification. 
 
Microglia polarization. Microglia were either left untreated or treated overnight with 
IFNγ (20 ng/ml) and LPS (0127:B8, 100 ng/ml), IL-13 (50ng/ml), or IL-10 (10ng/ml) 
(all from Sigma-Aldrich; <1 EU/μg). Conditioned media was collected and stored at -
20°C. Contaminating astrocytes were < 7% of the culture in all polarization states 
(data not shown). ELISAs for TNFα, IGF-1, and IL-10 were used according to the 
manufacturer’s instructions (R&D Systems). Absorbance was read at 450nm on a 
spectrophotometer and sample concentrations calculated using an equation generated 
from a standard curve. 3-5 independent supernatant sets were used. The rapid 
depolarization of microglia in the absence of polarizing factors (data not shown) 
required these to be present during conditioning of media; polarizing factors alone 
were directly applied to OPCs as a control. 
 
Protein extraction & Western blotting. Lysates were generated using RIPA buffer 
(Thermo Scientific) supplemented with 1% protease inhibitor cocktail set III 
ethylenediaminetetraaceticacid (EDTA)-free (Calbiochem). Protein concentrations 
were determined using the Pierce BCA Protein Assay Kit according to the 
manufacturer’s instructions. Samples were diluted in Laemmli buffer [200mM Tris-
HCl pH6.8 (Sigma-Aldrich), 8% sodium dodecyl sulphate (Sigma-Aldrich), 40% 
glycerol (BioRad), 0.2% bromophenol blue (Sigma) and 5% β-mercaptoethanol 
(Sigma)], heated at 95ºC for 2 min, and 10 µg of protein was loaded onto an 
Nature Neuroscience 16, 1211–1218 (2013) doi:10.1038/nn.3469
 34
acrylamide gel (4-20%; Thermo Scientific).  Gel electrophoresis was performed in 
Tris-hydroxyethyl piperazineethanesulfonic acid (HEPES)-sodium dodecyl sulphate 
(SDS) running buffer (Thermo Scientific) at 150 V for 45 minutes and proteins 
transferred onto polyvinylidene difluoride (PVDF) membranes (Millipore) for 2h at 
400 mA in 10% transfer buffer [3% Tris-HCl (Sigma-Aldrich), 15% glycine (Sigma-
Aldrich), pH 8.3] and 20% methanol (Fisher Chemical) diluted in H2O.  Membranes 
were blocked with 5% powdered milk (<1% fat) in Tris-buffered saline (TBST) [4% 
sodium chloride (NaCl), 0.1% potassium chloride (KCl), 1.5% Tris-HCl, 0.1% 
Tween-20 (all from Sigma-Aldrich), pH 7.4] for 1 h at room temperature on an orbital 
shaker, and incubated overnight at 4ºC with mouse anti-iNOS (1:500; BD Bioscience) 
or rabbit anti-MR antibody (1:500; Abcam), washed thrice in TBST for 5 min, and 
incubated with horseradish peroxidase (HRP)-IgG secondary antibody conjugates 
(1:10,000; Calbiochem) for 1 h at room temperature.  Chemiluminescent substrate 
detection reagent RapidStep ECL Reagent (Calbiochem) and autoradiography film 
processing was performed.  For loading control purposes, all membranes were re-
blotted with anti-mouse (1:1000, Millipore) or anti-rabbit glyceraldehyde-3-phosphate 
dehydrogenase antibody (GAPDH; 1:1000, Sigma).   
 
Transfilter microchemotaxis assays. OPCs were plated on PDL-coated poly-
carbonate transwell culture inserts (Corning) in a 24 well plate at 5x104 cells/ well in 
basal culture media supplemented with fibroblast growth factor (FGF2). Platelet 
derived growth factor (PDGF) was excluded from the media due to its 
chemoattractant properties. Microglia media, conditioned media, or recombinant 
polarization factors were added to the bottom chamber in a 1:1 ratio with OPC culture 
media. Cells were allowed to migrate for <24 hrs at 37°C to avoid confounding 
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effects of conditioned media on proliferation. Cells were fixed for 1h with 4% PFA 
and 0.1% glutaraldehyde. Unmigrated cells on the upper side of the transwell were 
scraped off with a cotton swab, and cells that had migrated to the bottom of the 
transwell were visualized with Hoechst. Each condition was performed in 
quadruplicate wells and the experiment was repeated with 3 independent OPC 
samples and 3 conditioned media samples. 4 images were taken per well at 20X 
magnification for quantification purposes. 
 
Immunocytochemistry. Cells were fixed with 4% paraformaldehyde (Sigma) for 10-
15 min and blocked for 30 minutes at room temperature. Primary antibodies were 
diluted in blocking solution and applied for 1 h at room temperature (as listed above). 
Cells were incubated with fluorescently conjugated secondary antibodies (1:1000, 
Invitrogen) for 1 h at room temperature, counterstained with Hoechst (5 µg/ml), and 
coverslipped with fluoromount-G. Apoptotic cells were visualized by TUNEL assay 
(Promega) according to the manufacturer’s instructions. Positive controls for 
apoptosis included addition of 70% ethanol to live cells, and incubation of fixed cells 
with DNase (10 units/ml) for 10 min. For proliferation studies, BrdU-treated OPCs 
were fixed with ice-cold 70% ethanol in 50 mM glycine buffer, pH 2.0, for 20 
minutes. Permeabilization was performed with 2M HCl for 15 min at 37°C, which 
was neutralized by 3 washes in TBE buffer (1M Tris, 0.9M Boric acid, 0.01M EDTA; 
GIBCO).  
 
RNA extraction, reverse transcription, and quantitative real-time polymerase 
chain reaction array (qRT-PCR). Microglia were washed with PBS, lysed with 
RLT buffer supplemented with beta-mercaptoethanol, scraped, and homogenized with 
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21 guage needles. RNA extraction was performed using the Qiagen minikit (with on-
column DNase treatment), and reverse transcription performed using the Invitrogen 
Superscipt First-strand synthesis system for RT-PCR, both according to the 
manufacturer’s instructions. A custom qPCR array plate (SABiosciences) was 
designed to include primers for M1 and M2-associated genes that were detected as 
being significantly upregulated in a microarray screen of a remyelinating lesion of the 
rat caudal cerebellar peduncles in vivo 18. qPCR was carried out using the Roche Light 
Cycler 480. Cp values were obtained using the second derivative maximum method 
and ∆Cp was calculated by subtracting the average value from 5 housekeeping genes 
(Actb, B2m, Ldha, Pgk1, Hprt1). Expression is represented as 2-∆Cp. 
 
Organotypic cerebellar slice cultures. Cerebellum and attached hindbrain were 
isolated from P0-P2 CD1 mouse pups, sectioned sagitally at 300 µm on McIlwain 
tissue chopper, and plated onto Millipore-Millicel-CM mesh inserts (Fisher Scientific) 
in 6 well culture plates at 6 slices per insert. Media was composed of 50% minimal 
essential media, 25% heat-inactivated horse serum, 25% Earle’s balanced salt solution 
(all from GIBCO), 6.5 mg/ml glucose (Sigma), 1% penicillin-streptomycin,  and 1% 
glutamax, and was changed every 2-3 days. Demyelination was induced at 21 days in 
vitro (DIV) by a 20 hr incubation in 0.5 mg/ml lysolecithin, slices were washed in 
media for 10 min. After recovery, slices were treated for 6 days with M2a microglia 
conditioned media and either anti-activin-A goat IgG or isotype control (200 ng/ml). 
Slices were fixed in 4% PFA for 1 hr. Primary antibody (as listed above) was applied 
for 48 hr at 4°C, slices were washed thrice, and fluorescently conjugated antibody was 
applied overnight at 4°C. Slices were mounted onto glass slides using Fluoromount-
G. 
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Multiple Sclerosis Tissue. Post-mortem tissue from MS patients and controls that 
died of non-neurological causes were obtained via a UK prospective donor scheme 
with full ethical approval from the UK Multiple Sclerosis Tissue Bank 
(MREC/02/2/39). Diagnosis of MS was confirmed by neuropathological means by Dr 
F. Roncaroli (Consultant Neuropathologist, Imperial College London) and clinical 
history was provided by Dr R. Nicholas (Consultant Neurologist, Imperial College 
London) (summarized in Supplementary Table 1 online). The death-to-tissue 
preservation interval was from 7-31 h. Brain blocks numbered by the brain bank 
locate the position of the block in the brain (i.e. coronal plane: anterior (A) and 
posterior (P) halves at the mamillary bodies, and 1 cm coronal slices numbered 
sequentially, vertical plane: 2×2 cm blocks identified by letters (A–E) and by numbers 
in the horizontal plane). Snap frozen unfixed tissue blocks (2×2×1 cm) were cut at 10 
μm and stored at −80°C. MS lesions were classified according to the International 
Classification of Neurological Disease using luxol fast blue staining and CD68+ 
immunoreactivity. We analysed 5 control blocks and 13 tissue blocks from 10 MS 
patients; in total, we analysed 10 active lesions, 6 chronic active lesions, 11 chronic 
inactive lesions, and 14 remyelinated lesions (Supplementary Table 1 online). 
Approximately 170 fields of 50 µm x 50 µm were counted per lesion and counts were 
multiplied to determine density of immunopositive cells/ mm2. Sections were fixed in 
4% PFA for 1 h at room temperature, washed in PBS, and permeabilized in methanol 
for 10 min at -20°C. Following washes in 0.3% Triton X-100 in PBS, sections were 
microwaved in Vector unmasking solution for 10 min, and endogenous peroxidase 
activity blocked for 5 min (Envision blocking solution, DAKO). Primary antibody 
was prepared in antibody diluent (AMS Biotechnology (Europe) Ltd) and applied 
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overnight in a humid chamber at 4°C. Antibodies used include mouse anti-iNOS (BD 
Bioscience, 610329, 1:100), rabbit anti-mannose receptor (Abcam, ab64693, 1:600), 
and mouse anti-CD68 (DAKO, clone KP1 M0814, 1:100). Following 3 washes in 
0.3% Triton X-100 in PBS, anti-mouse or –rabbit peroxidase conjugated secondary 
antibody was applied for 2h at room temperature in a humid chamber. Sections were 
washed in PBS and stains visualized by 3,3’-Diaminobenzidine (DAB) chromagen. 
Following washes in water, sections were dehydrated in increasing concentrations of 
acetone, then xylene, and coverslipped. For co-localization stains, sections were 
blocked with 10% normal horse serum and 0.1% Triton-X 100 for 1h, antibodies 
applied overnight as above, and fluorescently conjugated secondary antibodies 
(Invitrogen) applied for 2h with Hoechst counterstain. 
 
Quantification and statistical analysis. Lesion pixel counts and area quantification 
for MAG and MBP expression were performed using 10X objective images 
thresholded using Image J (NIH). The area of MOG and MBP co-localization in 40X 
objective images was obtained with Image J using the RG2B Colocalization Plugin 
followed by area quantification. All manual cell counts were performed in a blinded 
manner. Data are represented as mean ± s.e.m.. No statistical methods were used to 
predetermine sample sizes but these were similar to those generally employed in the 
field. Data was first tested for normality using the Kolmogorov-Smirnov test.  
Multiple comparisons within the same data set were analyzed by one-way ANOVA 
with Newman-Keuls post-hoc test, or Kruskal-Wallis test and Dunn’s multiple 
comparison test. Single comparisons to control were made using 2-tailed Student’s t-
test or Mann-Whitney test. P values of <0.05 were considered statistically significant. 
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Data handling and statistical processing was performed using Microsoft Excel and 
GraphPad Prism Software. 
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Supplementary Figure 1 Additional characterization of polarization in corpus 
callosum lesions.  
(a)  Representative images of sham PBS-injected lesions at 3 and 10 dpl 
immunostained for iNOS (green), Arg-1 (red), and CD68 (white). (b) Co-localization 
of iNOS and Arg-1 in microglia/ macrophage cell bodies (CD68; arrows) and 
processes (F4/80). 3 and 10 dpl lesions immunostained for additional M1 markers (c; 
TNFα, CD16/32) and M2 markers (d; MR, IGF-1). All scale bars, 25 µm. 
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Supplementary Figure 2 Switch from M1- to M2-dominant response in 
remyelinating lesions of the rat caudal cerebellar peduncle.  
(a) Oligodendroglial lineage cell responses following induction of demyelination of 
the caudal cerebellar peduncle by stereotaxic injection of ethidium bromide (EtBr). 
Scale bar, 100 µm. (b) Injection of demyelinating toxin induces accumulation of 
microglia (CD68+; red) at 5 dpl. Recovery of myelin protein expression is observed 
with re-expression of MAG at 10 dpl (c, centre) and MBP at 21 dpl (c, right). (d) 
Microglia/ macrophages (CD68+; purple) are present at 5 dpl, increase in abundance 
at 10 dpl, and decrease in number by 21 dpl. (e) Representative images of lesions 
immunostained for iNOS (green) and Arg-1 (red). Percentage (f) and mean number 
(g) of iNOS+ M1, Arg-1+ M2, and unpolarized (iNOS– Arg1–) cells per field ± s.e.m. 
at 5, 10, and 21 dpl. One-way ANOVA and Newman-Keuls post test, *p<0.05, 
**p<0.01. (n=3, df=26, 17, respectively). (h) 5 and 10 dpl sections immunostained for 
additional M1 (TNFα, CD16/32) and M2 (IGF-1, MR) markers. All other scale bars, 
25 µm. 
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Supplementary Figure 3 Polarization of cultured microglia to M1 and M2 
phenotypes.  
(a) Representative images of microglia immunostained against M1 markers iNOS, 
CD86, CD16/32 (top) and M2 markers MR, Arg-1, and interleukin-1 receptor 
antagonist (IL1Ra) (bottom). Scale bar, 25 µm. (b) Mean percentage of iNOS+ or 
MR+ cells of total CD68+ cells ± s.e.m.. Kruskal-Wallis test and Dunn’s multiple 
comparison post-hoc test, *p<0.05, **p<0.01, ***p<0.001. (n=4) (c) Cropped 
Western blots showing expression of iNOS with IFNγ/LPS treatment and increase in 
MR expression with IL-13 or IL-10 treatment, with loading control GAPDH. ELISAs 
used to assay conditioned media for levels of TNFα (d; P=0.0004, n=5, df=8), IGF-1 
(e; P=0.0330, n=3, df=4), and IL-10 (f; P=0.0051, n=5, df=8), presented as mean fold 
over M0 control ± s.e.m. demonstrating polarization to M1, M2a, and M2c, 
respectively. A small yet significant increase in IL-10 secretion was observed with 
IFNγ/ LPS treatment (P =0.0081). Polarizing factors alone were included in the assay 
as a control and did not show detectable levels relative to those measured in 
conditioned media (d-f). 2-tailed Student’s t-test. 
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Supplementary Figure 4 M1 and M2 associated gene expression in cultured 
microglia. 
(a) M1- and M2-associated genes were identified from a previously performed 
microarray18 as being significantly upregulated during remyelination of the rat caudal 
cerebellar peduncles (CCP). These genes were selected for a custom qPCR array to 
assess gene expression profiles of polarized microglia in vitro. (b) Confirmation of 
expression of additional polarization markers CD86, CCL2, CXCL11, and TGFβ2 in 
iNOS+ or Arg-1+ cells in the rat CCP. Scale bar, 5 µm. Microglia treated with 
IFNγ/LPS (M1), IL-13 (M2a), and IL-10 (M2c) were analyzed for gene expression 
levels of (c) Cd86, (d) Cxcl11, (e) Ccl2, (f) Fcgr2a (Cd32), (g) Mrc1(mannose 
receptor), (h) Tgfb2, and (i) Arg1, values are represented as 2-ΔCp ± s.e.m. 
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Supplementary Figure 5 M1 and M2 microglia conditioned media increase OPC 
proliferation and migration.  
OPCs were treated with microglia conditioned media for 3d. Polarizing factors 
present in the conditioned media (IFNγ/LPS, IL-13, and IL-10) were directly applied 
to OPCs as a control. (a) Representative images of OPCs immunostained against NG2 
(green) and the proliferative marker Ki67 (red). Double-positive cells are highlighted 
by arrows. Scale bar, 25 µm. (b) Number of NG2+ cells per field was increased with 
M0 (P=0.005), M1 (P=0.00188), M2a (P=0.00382), M2c (P=0.0119) conditioned 
media (CM), and IL-10 (P=0.0029) compared to control (n=5, df=8). (c) 
Ki67+/NG2+ cells were increased with M0 (P=0.0084), M1 (P=0.0362), M2a 
(P=0.0194), M2c (P=0.0192) conditioned media (n=4, df=6) (d) BrdU+ cells were 
increased with M1 (P=0.042), M2a (P=0.0083) and M2c conditioned media 
(P=0.0423) (n=4, df=6). Values from conditioned media-treated conditions (black 
bars) and polarizing factors alone (grey bars) were normalized to control 
(unconditioned media, white bars) in (c) and (d), and are represented as mean ± 
s.e.m., 2-tailed Student’s t-test. (e) Number of OPCs ± s.e.m. migrated towards 
microglia conditioned media (black bars), or polarizing factors alone (grey bars), 
normalized to values in control (unconditioned media, white bar) showing 
chemotactic properties of both M1 and M2 conditioned media. Kruskal-Wallis test 
and Dunn’s multiple comparison post-test, **p<0.01, ***p<0.001. (n=3). 
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Supplementary Figure 6 M2 polarized microglia conditioned media promotes the 
survival of OPCs in a death-inducing environment.  
OPCs were treated with microglia conditioned media for 3d in media devoid of serum 
and growth factors. Polarizing factors present in the conditioned media (IFNγ/LPS, 
IL-13, and IL-10) were directly applied to OPCs as a control. (a) Representative 
images of OPCs under basal growth supplemented conditions, grown in deprivation 
media alone, or supplemented with microglia conditioned media. OPCs were 
immunostained against NG2 (red) and apoptotic OPCs were visualized by TUNEL 
assay (green). Scale bar, 50 µm. (b) Mean percentage of TUNEL+ NG2+ OPCs 
normalized to control supplemented with growth factors and media ± s.e.m.. DNase 
and ethanol treatment were positive controls for TUNEL positivity. Application of 
microglia conditioned media to OPCs under normal growth conditions did not induce 
apoptosis (data not shown). Kruskal-Wallis test and Dunn’s multiple comparison 
post-test, *p<0.05, **p<0.01. (n=6).  
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Supplementary Figure 7 Selective depletion of M1 polarized microglia/ 
macrophages using gadolinium chloride. 
(a) Representative images of M1 (iNOS+; left) and M2a (MR+; right) microglia 
treated with 270 µm GdCl3 and apoptosis assessed by TUNEL assay (green nuclei). 
Apoptotic cells are indicated by arrowheads, and were iNOS+ and MR–. Scale bar, 25 
µm. (b) Percentage of TUNEL+ M1 microglia treated with vehicle (ctrl), or GdCl3 
(0.27-270 µm). Mann-Whitney test, P=0.0286. (n=4). (c) Mean percentage of 
TUNEL+ cells ± s.e.m. in M0, M1, M2a, and M2c polarized microglia treated with 
vehicle or 270 µm GdCl3. One-way ANOVA and Newman-Keuls post-hoc test, 
**p<0.01 (n=6, df=54). (d) GFAP immunostaining in representative control and 
GdCl3-injected lesions shows no difference in astrocyte reactivity. Scale bar, 25 µm. 
(e) Percentage of iNOS+ or Arg1+ cells in control or GdCl3-injected lesions, 
P=0.0135 (iNOS), 0.0319 (Arg1), 2-tailed Student’s t-test (n=5, df=8). (f) GdCl3-
injected lesions immunostained for M1 markers (iNOS, TNFα, CD16/32) and M2 
markers (MR, IGF-1) at 3 dpl. Scale bar, 25 µm. (g) NG2+ (n=4, df=6) and Nkx2.2+ 
(n=5, df=8) cells per field in control and GdCl3-treated lesions at 3 dpl. 2-tailed 
Student’s t-test, p>0.05. (h) Mean area of MBP and MOG co-localization, fold over 
control ± s.e.m. in lesions at 21 dpl. P=0.081, 2-tailed Student’s t-test (n=6, df=10). 
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Supplementary Figure 8 Selective depletion of M2 polarized microglia/ 
macrophages using mannosylated clodronate liposomes. 
(a) Representative images of iNOS+ M1 and MR+ M2a microglia treated with MCLs 
(1:5) and assessed for apoptosis by TUNEL assay. In M1 polarizing conditions, 
iNOS+ cells were TUNEL– (arrows); TUNEL+ cells were iNOS– (arrowheads). In 
M2a polarizing conditions, TUNEL+ cells were MR+ (arrowheads), whereas MR– 
cells were TUNEL– (arrows). (b) Mean percentage of TUNEL+ cells ± s.e.m. in M0, 
M1, M2a, and M2c polarized microglia treated MCLs (1:5 dilution), normalized to 
values from M0 conditions. P=0.027 (M1 vs. M2a), P=0.013 (M1 vs. M2c), 2-tailed 
Student’s t-test (n=6, df=10). Mean percentage of TUNEL+ cells ± s.e.m. in M2a (c, 
P=0.015, df=7) and M2c (d, P=0.0251, 0.0016, 0.03 for 1:50, 1:10, 1:5, respectively, 
df=6) microglia treated with MCLs (1:200-1:5; black bars) compared to control 
(white bars) (n=4). Mean numbers of microglia per field ± s.e.m. for M2a (e, P=0.02, 
0.03, 0.009, 0.007 for 1:100, 1:50, 1:10, 1:5, respectively, df=6) and M2c (f; 
P=0.0003, <0.0001, 0.0005, 0.0005 for 1:100, 1:50, 1:10, 1:5, respectively, df=6) 
polarized cells treated with MCLs (1:200-1:5; black bars) compared to control (white 
bars), 2-tailed Student’s t-test (n=4). (g) Percentage of iNOS+ M1, Arg-1+ M2, or 
unpolarized (iNOS–, Arg-1–) cells per field ± s.e.m. in control and MCL-injected 
lesions at 10 dpl. P<0.0001, 2-tailed Student’s t-test (n=5, df=8). (h) MCL-injected 
lesions immunostained for additional M1 (iNOS, TNFα, CD16/32) and M2 markers 
(MR, IGF-1). Scale bar, 25 µm. (i) Mean area of MBP and MOG colocalization fold 
over control ± s.e.m. in lesions at 21 dpl. 2-tailed Student’s t-test, P=0.0002 (n=6, 
df=10). (j) Axons (NF+) were detectable running through the lesion (MBP–) at 10 dpl 
following MCL injection. (k) MCL injection did not influence astrocytes (GFAP+) 
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within the lesion. Scale bar, 25 µm. (l) Total numbers of Nkx2.2+ OPCs ± s.e.m. in 
control and MCL injected lesions. 2-tailed Student’s t-test, p>0.05 (n=4, df=6). 
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Supplementary Figure 9 Expression of activin-A receptors on cells in remyelinating 
lesions.  
Representative images of oligodendrocytes (CC1+), microglia/ macrophages 
(CD68+), astrocytes (GFAP+), and neurons (axons; NF+) with expression (arrows), 
or lack thereof, of activin-A receptors Acvr2A and Acvr2B. Scale bar, 10 µm. 
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Supplemental Table 1. Human brain tissue samples 
Lesions Analyzed  
 
C
lassific-
ation 
Sex 
A
ge 
D
isease 
duration 
(yrs)
 
B
lock 
A
ctive 
C
hronic 
A
ctive 
C
hronic 
Inactive 
R
em
yel-
inated 
P2E3 0 0 2 2 SPMS M 46 8 
P3E3 1 0 1 1 
SPMS F 49 14 A3D3 3 0 0 0 
SPMS M 40 9 P3B4 1 0 1 3 
SPMS F 60 21 P3C3 1 1 1 0 
A2D7 1 0 0 0 SPMS F 34 21 
A2E2 1 0 1 1 
PPMS M 37 27 P4D1 0 0 1 3 
SPMS F 57 27 P3D1 0 0 0 2 
A2B3 0 1 1 0 SPMS F 46 25 
P2C4 0 2 0 1 
SPMS F 42 19 A2C2 2 0 0 1 
 
 
 
 
 
Multiple 
Sclerosis 
Patients 
SPMS F 57 19 P3C4 0 2 3 0 
                                                                                   TOTAL 10 6 11 14 
Carcinoma of 
the lung 
metastasized 
M 77 - P3B4 - - - - 
Cardiac failure M 64 - P2D2 - - - - 
Carcinoma of 
the tongue 
M 35 - P3B3 - - - - 
Ovarian 
cancer 
F 60 - P3D2 - - - - 
 
 
 
 
Non-
Neurological 
Controls 
Myelodysplast
-ic syndrome, 
Rheumatoid 
Arthritis 
M 82 - A2C7 - - - - 
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